Hepatitis B Virus Associated Liver Disease

Infectious Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Biotest Pharmaceuticals
Biotest PharmaceuticalsGermany - Dreieich
1 program
1
Hepatitis B Immune GlobulinPhase 1/21 trial
Active Trials
NCT01421212CompletedEst. Feb 2002

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Biotest PharmaceuticalsHepatitis B Immune Globulin

Clinical Trials (1)

NCT01421212Biotest PharmaceuticalsHepatitis B Immune Globulin

Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation

Start: Nov 1999Est. completion: Feb 2002
Phase 1/2Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space